Sarah R Amend
Cited by
Cited by
Integrins and bone metastasis: integrating tumor cell and stromal cell interactions
JG Schneider, SR Amend, KN Weilbaecher
Bone 48 (1), 54-65, 2011
Murine hind limb long bone dissection and bone marrow isolation
SR Amend, KC Valkenburg, KJ Pienta
JoVE (Journal of Visualized Experiments), e53936, 2016
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
KV Myers, SR Amend, KJ Pienta
Molecular cancer 18 (1), 1-14, 2019
Revisiting seed and soil: examining the primary tumor and cancer cell foraging in metastasis
AE De Groot, S Roy, JS Brown, KJ Pienta, SR Amend
Molecular Cancer Research 15 (4), 361-370, 2017
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
SR Amend, G Torga, KC Lin, LG Kostecka, A de Marzo, RH Austin, ...
The Prostate 79 (13), 1489-1497, 2019
Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype
SR Amend, KJ Pienta
Oncotarget 6 (12), 9669, 2015
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
Thrombospondin‐1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts
SR Amend, O Uluckan, M Hurchla, D Leib, D Veis Novack, M Silva, ...
Journal of Bone and Mineral Research 30 (1), 106-115, 2015
Ecological paradigms to understand the dynamics of metastasis
SR Amend, S Roy, JS Brown, KJ Pienta
Cancer letters 380 (1), 237-242, 2016
The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol [S]
MS Leduc, M Lyons, K Darvishi, K Walsh, S Sheehan, S Amend, A Cox, ...
Journal of lipid research 52 (6), 1139-1149, 2011
AXL is a putative tumor suppressor and dormancy regulator in prostate cancer
HD Axelrod, KC Valkenburg, SR Amend, JL Hicks, P Parsana, G Torga, ...
Molecular Cancer Research 17 (2), 356-369, 2019
Convergent evolution, evolving evolvability, and the origins of lethal cancer
KJ Pienta, EU Hammarlund, R Axelrod, SR Amend, JS Brown
Molecular Cancer Research 18 (6), 801-810, 2020
Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types
SR Amend, WC Wilson, L Chu, L Lu, P Liu, D Serie, X Su, Y Xu, D Wang, ...
PloS one 10 (5), e0127828, 2015
Poly‐aneuploid cancer cells promote evolvability, generating lethal cancer
KJ Pienta, EU Hammarlund, R Axelrod, JS Brown, SR Amend
Evolutionary Applications 13 (7), 1626-1634, 2020
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium
L Dong, RC Zieren, K Horie, CJ Kim, E Mallick, Y Jing, M Feng, ...
Journal of extracellular vesicles 10 (2), e12044, 2020
Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration
P Parsana, SR Amend, J Hernandez, KJ Pienta, A Battle
BMC cancer 17 (1), 1-14, 2017
Extracellular vesicle isolation from human renal cancer tissue
RC Zieren, L Dong, PM Pierorazio, KJ Pienta, TM de Reijke, SR Amend
Medical Oncology 37 (4), 1-11, 2020
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
KJ Pienta, EU Hammarlund, RH Austin, R Axelrod, JS Brown, SR Amend
Seminars in Cancer Biology, 2020
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
KJ Pienta, EU Hammarlund, JS Brown, SR Amend, RM Axelrod
Proceedings of the National Academy of Sciences 118 (7), 2021
The system can't perform the operation now. Try again later.
Articles 1–20